References
- Agargun MY, Kara H, Solmaz M. (1997a). Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry. 58:249–51.
- Agargun MY, Kara H, Solmaz M. (1997b). Subjective sleep quality and suicidality in patients with major depression. J Psychiatr Res. 31:377–81.
- Almeida OP, Pfaff JJ. (2005). Sleep complaints among older general practice patients: Association with depression. Br J Gen Pract. 55:864–66.
- Brainard GC, Hanifin JP, Greeson JM, et al. (2001). Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J Neurosci. 21:6405–12.
- Burkhart K, Phelps JR. (2009). Amber lenses to block blue light and improve sleep: A randomized trial. Chronobiol Int. 26:1602–12.
- Cajochen C, Frey S, Anders D, et al. (2011). Evening exposure to a light-emitting diodes (LED)-backlit computer screen affects circadian physiology and cognitive performance. J Appl Physiol. 110:1432–38.
- Chang AM, Aeschbach D, Duffy JF, Czeisler CA. (2015). Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proc Natl Acad Sci U S A. 112:1232–37.
- Cuijpers P, Smit F. (2002). Excess mortality in depression: A meta-analysis of community studies. J Affect Disord. 72:227–36.
- Esaki Y, Kitajima T, Ito Y, et al. (2016). Wearing blue light-blocking glasses in the evening advances circadian rhythms in the patients with delayed sleep phase disorder: An open-label trial. Chronobiol Int. 33:1037–44.
- Fava M, McCall WV, Krystal A, et al. (2006). Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 59:1052–60.
- Ferrari AJ, Charlson FJ, Norman RE, et al. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. Plos Med. 10:e1001547.
- Germain A, Kupfer DJ. (2008). Circadian rhythm disturbances in depression. Hum Psychopharmacol. 23:571–85.
- Gordijn MC, Beersma DG, Bouhuys AL, et al. (1994). A longitudinal study of diurnal mood variation in depression: Characteristics and significance. J Affect Disord. 31:261–73.
- Greenberg PE, Fournier AA, Sisitsky T, et al. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 76:155–62.
- Guzel Ozdemir P, Boysan M, Smolensky MH, et al. (2015). Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder. J Clin Psychiatry. 76:e645–654.
- Hattar S, Liao HW, Takao M, et al. (2002). Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science. 295:1065–70.
- Hayasaka Y, Purgato M, Magni LR, et al. (2015). Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. J Affect Disord. 180:179–84.
- Henriksen TE, Skrede S, Fasmer OB, et al. (2016). Blue-blocking glasses as additive treatment for mania: A randomized placebo-controlled trial. Bipolar Disord. 18:221–32.
- Horne JA, Ostberg O. (1976). A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 4:97–110.
- Inada T, Inagaki A. (2015). Psychotropic dose equivalence in Japan. Psychiatry Clin Neurosci. 69:440–47.
- IsHak WW, Greenberg JM, Balayan K, et al. (2011). Quality of life: The ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry. 19:229–39.
- Kayumov L, Casper RF, Hawa RJ, et al. (2005). Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab. 90:2755–61.
- Khalsa SB, Jewett ME, Cajochen C, Czeisler CA. (2003). A phase response curve to single bright light pulses in human subjects. J Physiol. 549:945–52.
- Lam RW, Levitan RD. (2000). Pathophysiology of seasonal affective disorder: A review. J Psychiatry Neurosci. 25:469–80.
- Lam RW, Levitt AJ, Levitan RD, et al. (2015). Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: A randomized clinical trial. JAMA Psychiatry. 73:56–63.
- Lewy AJ, Emens J, Jackman A, Yuhas K. (2006). Circadian uses of melatonin in humans. Chronobiol Int. 23:403–12.
- Lewy AJ, Sack RL, Singer CM, et al. (1988). Winter depression and the phase-shift hypothesis for bright light’s therapeutic effects: History, theory, and experimental evidence. J Biol Rhythms. 3:121–34.
- Lewy AJ, Wehr TA, Goodwin FK, et al. (1980). Light suppresses melatonin secretion in humans. Science. 210:1267–69.
- Martiny K, Lunde M, Unden M, et al. (2005). Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales. Acta Psychiatr Scand. 111:453–59.
- Morin CM, Benca R. (2012). Chronic insomnia. Lancet. 379:1129–41.
- Paykel E. (1990). Validity of the Hamilton depression scale in general practice. In Bech P, Coppen A, eds. The Hamilton scales. Berlin: Springer, pp. 40–47.
- Perils ML, Smith MT. (2008). How can we make CBT-I and other BSM services widely available? J Clin Sleep Med. 4:11–13.
- Phelps J. (2008). Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses. 70:224–29.
- Sasseville A, Paquet N, Sevigny J, Hebert M. (2006). Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J Pineal Res. 41:73–78.
- Thapan K, Arendt J, Skene DJ. (2001). An action spectrum for melatonin suppression: Evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol. 535:261–67.
- Tolle R, Goetze U. (1987). On the daily rhythm of depression symptomatology. Psychopathology. 20:237–49.
- Tsuno N, Besset A, Ritchie K. (2005). Sleep and depression. J Clin Psychiatry. 66:1254–69.
- Van Der Lely S, Frey S, Garbazza C, et al. (2015). Blue blocker glasses as a countermeasure for alerting effects of evening light-emitting diode screen exposure in male teenagers. J Adolesc Health. 56:113–19.
- Waraich P, Goldner EM, Somers JM, Hsu L. (2004). Prevalence and incidence studies of mood disorders: A systematic review of the literature. Can J Psychiatry. 49:124–38.
- Watanabe N, Furukawa TA, Shimodera S, et al. (2011). Brief behavioral therapy for refractory insomnia in residual depression: An assessor-blind, randomized controlled trial. J Clin Psychiatry. 72:1651–58.